Director, Launch Heor

Bringing life-changing medicines to millions of people, Novartis sits at the intersection of cutting-edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs & an in-house marketplace for rotations & project work. With a strong medicines pipeline our current transformation will not just deliver growth for our business but continue to allow us to bring innovative medicines to patients quickly.
- Launch HEOR Directors will partner across GDD, TAs, MAP, Regions and priority countries to develop and implement impactful and winning HEOR, IEP and access-relevant evidence generation strategies and tactics such that enable priority countries to secure broad and rapid access, reimbursement, and adoption for priority pre-launch and launch stage IM brands, enhanced healthcare system value proposition and better patient outcomes, and that support new commercial models.
- Launch HEOR Directors will be responsible to develop and deliver all aspects of the HEOR strategy and execution for priority assets from FDP through launch and post-launch until handover to IBBI. This role will specifically focus on pre-launch and Launch assets residing within International TA teams. With International TAs, early HEOR Directors will co-develop HEOR strategies and tactics with specific focus on priority countries (US, CN, DE, JP), major HTA architypes (e.g., UK/CAN) and Budget Impact archetypes (e.g. Italy and/or Spain) needs and feasibility. They will work in close partnership, collaborate and influence strategic TAs cross-functional teams, GPTs, R&D teams in NIBR & GDD, Region and priority Country teams to maximize patient outcomes and access and healthcare system value for early IM assets.
- Your responsibilities include, but are not limited to:
- Develop and deliver winning HEOR strategy and tactics, with high quality and on-time availability, including outcomes research and other relevant access and healthcare systems evidence and HEOR deliverables (incl. Global Value Dossier, Cost-effectiveness Models, Budget Impact Models, evidence synthesis, PCO or PRO strategy, access-enabling studies, etc.)
- Ensure that payer and healthcare needs are reflected into Phase 3b/4, RWE and integrated evidence plans to meet the needs of external experts and institutions involved in reimbursement, pricing, access and healthcare systems decisions.
- Collaborate across divisions and functions to ensure effective integration of HEOR and payer evidence deliverables (global value dossiers, cost effectiveness and budget impact models) into integrated product strategies, to enable and support in-country reimbursement submissions / negotiations
- Partner closely with Regional and Country teams to design and oversee rollout of global HEOR and payer-evidence strategies and to support local launch preparations and activities concerning access, HEOR, HTA and payer interactions, to achieve reimbursement and other positive funding recommendations and optimal access.
- Interact with payers and relevant customer groups in priority countries, gather Country-level insights and feedback, integrate into winning HEOR and payer strategies and tactics, incorporating HEOR perspective in overarching cross-functional product strategies and tactics
- Establish and maintains relationships with key economic modelling, outcomes research and HEOR talent and leaders in the field, both outside and inside the company; Stay abreast of external developments, trends and other dynamics that affect the HEOR and HTA domain and competitive position of Novartis assets; share learnings and facilitate hands-on utilization of HEOR deliverables throughout the broader organization.
- Support Head of Early HEOR, as well as Head of HEOR & PCO in external engagement (with HTA bodies, policy makers, regulatory agencies, HEOR scientific groups) to shape the HTA environment, the HEOR field and informs the organization on opportunities and risks.
- Embrace change, help implement the new ways of working from Transforming for Growth, develop and improve improved ways of working with a focus on flexibility and efficiency.

The role can be based in either Switzerland and/or USA.
- Our selection process will prioritize associates whose roles may be changing or may be impacted as a result of the Transforming for Growth reorganization.
The ideal location for this role is East Hanover, NJ but remote work may be possible (there may be some restrictions based on legal entity). Please note that this role would not provide relocation as a result. If associate is remote, all home office expenses and any travel/lodging to specific East Hanover, NJ for periodic live meetings will be at the employee’s expense. The expectation of working hours and travel (domestic and/or international) will be defined by the hiring manager.